PROCEPT BioRobotics Corporation
PRCT
$49.96
$1.452.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 1.36% | 16.90% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.36% | 16.90% | |||
| Cost of Revenue | 1.78% | 14.47% | |||
| Gross Profit | 1.12% | 18.32% | |||
| SG&A Expenses | 14.24% | 13.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.84% | 8.85% | |||
| Operating Income | -39.21% | 12.11% | |||
| Income Before Tax | -31.19% | 10.10% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -31.19% | 10.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -31.19% | 10.10% | |||
| EBIT | -39.21% | 12.11% | |||
| EBITDA | -42.21% | 13.47% | |||
| EPS Basic | -28.61% | 13.17% | |||
| Normalized Basic EPS | -28.60% | 13.13% | |||
| EPS Diluted | -28.61% | 13.17% | |||
| Normalized Diluted EPS | -28.60% | 13.13% | |||
| Average Basic Shares Outstanding | 2.00% | 3.51% | |||
| Average Diluted Shares Outstanding | 2.00% | 3.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||